BridgeBio

Overview

BridgeBio Pharma, Inc. is a biopharmaceutical organization headquartered in Palo Alto, California, with a mission to discover and deliver innovative medicines for patients suffering from genetic diseases and cancers driven by clear genetic causes. Using a unique hub-and-spoke model, BridgeBio's central hub provides support to independent subsidiaries, enabling rapid development and agility across multiple drug discovery programs focused on specific genetic indications.

Since its founding in 2015, the company has launched over 30 drug discovery programs and secured 18 Investigational New Drug (IND) applications, achieving three FDA approvals, including Attruby (acoramidis) for transthyretin amyloid cardiomyopathy in 2024. BridgeBio is committed to connecting advances in genetic science to patients with unmet needs, prioritizing patient outcomes and efficient global therapy delivery.

Basic Information

Contact Details

• Phone: +1 650-391-9740
• Website: bridgebio.com
• LinkedIn: linkedin.com/company/bridgebio

Key Focus Areas & Initiatives

• Biotechnology: pharmaceutical preparations
• Health care
• Biotechnology research
• Genetic disease pipeline
• Drug development
• Molecular biology
• Genetic disease clinical trials
• Genetic medicine innovation
• Biotechnology
• Genetic disease therapeutic platforms
• Gene therapies
• Genetic disease treatment development
• Clinical trials
• Precision medicine
• Rare disease treatment
• Cardiology
• Genetic disease treatment strategies
• Targeted therapies
• Biopharmaceutical
• FDA approvals
• Genetic disease biotech
• Genetic disease pipeline management
• Scientific rigor
• Clinical development
• Decentralized model
• Genetic disease innovation
• Genetic science breakthroughs
• Gene therapies for rare diseases
• Patient-centric
• Genome sequencing
• Research and development in the physical, engineering, and life sciences
• Biotech company
• Genetic research
• Biotech innovation
• Genetic disease market
• Genetic disease research partnerships
• Regulatory compliance
• Biotech
• Oncology
• Genetic disease unmet needs
• Genetic disease therapies
• Therapeutic technologies
• Scientific discovery
• Genetic disease targets
• Pipeline programs
• Global markets
• Pharmaceuticals
• Genetic mutations
• Genetic science
• Rare diseases
• Transformative medicines
• Regulatory milestones
• Healthcare
• Regenerative medicine
• Genetic disease drug candidates
• Patient-first
• Genetic disease patient populations
• B2B
• Biotech partnerships
• Oncology pipeline
• Genetic disease drug discovery
• Genetic disease research collaborations
• Small molecule drugs
• Genetic diseases
• Genetic disease research funding
• Orphan drugs
• Gene therapy
• Small molecule
• FDA approval
• Pipeline
• Innovative therapies
• Clinical research
• Healthcare partnerships
• Patient access
• Advanced clinical trials
• Competitive landscape
• Scientific innovation
• Drug discovery
• Market access
• Patient advocacy
• Regulatory affairs
• Genomic medicine
• Therapeutic development
• Pharmaceutical collaborations
• Early-stage research
• Patient solutions
• Preclinical studies
• Genetic targets
• Discovery platform
• Commercial infrastructure
• Healthcare collaboration
• Research capabilities
• Accelerated approval
• Biostatistics
• Molecular targets
• Drug candidates
• Market opportunity
• Therapeutic areas
• Healthcare investors
• Therapeutic pipeline
• Health, wellness & fitness
• Hospital & health care
• Medical

Technologies Used

• AI
• ANGEL LMS
• AWS Trusted Advisor
• Akamai CDN Solutions
• Amazon AWS
• Amazon Associates
• Amazon EC2
• Amazon WorkSpaces
• Atlassian Cloud
• BetterUp
• CallMiner Eureka
• Cisco Meraki MS
• Concur
• Coupa
• DatoCMS
• Dell EMC Data Protection Suite
• DocuSign
• FullStory
• Gem
• GoDaddy
• Google AdWords Conversion
• Google Analytics
• Google Search Console
• Google Tag Manager
• Greenhouse
• Greenhouse.io
• HPLC
• Jira
• LinkedIn Learning
• Marketo
• Microsoft 365
• Microsoft Active Directory Federation Services
• Microsoft Azure Monitor
• Microsoft Bing Speech API
• Microsoft Excel
• Microsoft Office
• Microsoft Office 365
• Microsoft PowerPoint
• Microsoft PowerShell
• Microsoft Teams Rooms
• Microsoft Word
• Mobile Friendly
• NLP
• Next.js
• Office365
• Okta
• Optimizely
• Outlook
• Perl
• PowerBI Tiles
• Python
• Reltio Connected Data Platform
• Remote
• SAP
• SAP Concur
• Salesforce
• Salesforce Marketing Cloud
• Sanity
• SharePoint
• Sizmek (MediaMind)
• Slack
• Spring
• Tableau
• UPS
• VNDLY
• Veeva CRM
• Veeva Systems
• Vercel
• VueJS
• WP Engine
• WebOffice
• WordPress.org
• Workday
• Zapier
• Zendesk
• Zoomdata

Affiliated Organizations & Regional Branches

• Eidos Therapeutics, Inc.